期刊文献+

多黏菌素对耐亚胺培南鲍氏不动杆菌的体外抗菌活性 被引量:1

In vitro Antibacterial Activity of Polymyxin Against Imipenem-resistant Acinetobacter baumannii
原文传递
导出
摘要 目的评价多黏菌素(多黏菌素B和多黏菌素E)对耐亚胺培南鲍氏不动杆菌的体外抗菌活性。方法2008年1月-2009年4月从临床感染患者送检标本中分离的299株鲍氏不动杆菌,按照对亚胺培南的耐药性分为亚胺培南耐药菌株和亚胺培南敏感菌株,并检测其对多黏菌素B、多黏菌素E等19种抗菌药物的敏感性。结果299株鲍氏不动杆菌主要分离自痰液标本(89.3%),科室中以ICU为主,分离占37.5%;检出耐亚胺培南菌167株,占55.9%;多黏菌素B、多黏菌素E对耐亚胺培南鲍氏不动杆菌的敏感率分别为97.0%和97.6%,显示了高度的敏感性;对耐亚胺培南鲍氏不动杆菌敏感性较高的其他抗菌药物还有头孢哌酮/舒巴坦(敏感率65.9%),其他抗菌药物敏感性均〈15.0%。结论多黏菌素对耐亚胺培南鲍氏不动杆菌具有良好的体外抗菌活性。 OBJECTIVE To evaluate the in vitro antibacterial activity of polymyxin (including polymyxin B and colistin)against imipenem-resistant Acinetobacter baumannii. METHODS All of the 299 strains of A. baumannii isolated from patients with infection during the period of Jan 2008 to Apr 2009 were identified and their drug resistance to 19 frequently used antibiotics were analyszed. RESULTS A total of 299 strains of A. baumannii were mainly isolated from sputum specimens(89. 3%) and ICU ward(37. 5%). Among all strains , 167 imipenemresistant isolates (accounted for 55. 9%) were detected. The sensitive rate to.polymyxin B and colistin against imipenem-resistant isolates were 97.0 % and 97.6%, respectively, and cefoperazone/sulbactam (65.9 %) was next to them. Besides, the sensitive rate to other antibiotics was less than 15. 0%. CONCLUSIONS Polymyxin demonstrates a powerful in vitro antibacterial activity against imipenem-resistant A. baumannii.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第3期388-390,共3页 Chinese Journal of Nosocomiology
关键词 多黏菌素 鲍氏不动杆菌 亚胺培南 药敏试验 Polymyxin Acinetobacter baumannii Imipenem Antimicrobial susceptibility test
  • 相关文献

参考文献13

  • 1Talbot GH, Bradley J, Edwards JE, et al. Bad bugs need drugs, an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America[J]. Clin Infect Dis,2006,42(5) :657-668.
  • 2Tan TY, Ng LS, Tan E, et al. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates [J]. J Antimierob Chemother, 2007,60(2): 421-423.
  • 3CLSI. Performance standards for antimicrobial susceptibility testing [S]. Seventeenth informational supplement. M100 S17. CLSI, 2007.
  • 4罗燕萍,王雪英,沈定霞,刘续春,曹敬荣,魏星.多黏菌素B与美罗培南对110株多药耐药鲍氏不动杆菌联合药敏研究[J].中华医院感染学杂志,2008,18(9):1312-1314. 被引量:8
  • 5Saugar JM, Rodriguez-Hernandez MJ, de la Torre BG,et al. Activity o5 cecropin A-melittin hybrid peptides against colistinresistant clinical strains of Acinetobacter baumannii : molecular basis for the differential mechanisms of action[J]. Antimicrob Agents Chemother,2006,50(4): 1251-1256.
  • 6Rodriguez-Hernandez MJ,Saugar J,Docobo-Perez F,etal. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baurnannii [J]. Antimicrob Chemother, 2006,58(1) : 95-100.
  • 7陈轶坚,吴卫红,吴湜,叶信予,吴菊芳.373株不动杆菌的药物敏感性试验[J].中国感染与化疗杂志,2007,7(3):194-197. 被引量:8
  • 8Rios FG, Luna CM, Maskin B, et al. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms[J]. Eur Respir J,2007,30(2):307-313.
  • 9Kasiakou SK,Michalopoulos A,Soteriades ES,etal. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis[J]. Antimicrob Agents Chemother, 2005,49 (8): 3136-3146.
  • 10Falagas ME,Kasiakou SK,Tsiodras S,et al. The use of intravenous and aerosolized polymyxins for the treatment of inlet tions in critically ill patients: a review of the recent literature [J]. ClinMedRes,2006,4(2):138-146.

二级参考文献21

共引文献14

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部